815 material Form 8-K filings that 659 companies we cover made with the SEC in March 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Alliant Energy entered into a $400 million term loan credit agreement on March 2, 2026, with U.S. Bank National Association as administrative agent. The agreement also allows an incremental term loan of up to $100 million, but no lender is obligated to provide it, and the loan matures March 1, 2027.
$400 million term loan facility, dated March 2, 2026
Up to $100 million incremental term loan; no lender obligated to provide it
Maturity date March 1, 2027; proceeds may fund working capital, capital expenditures and refinancing
Covenant requires debt-to-capital ratio of not greater than 65%; cross-default triggers at $100 million or more of debt
ClearThink 1 Acquisition Corp., a blank check company, closed its initial public offering of 12,500,000 units at $10.00 per unit on February 25, 2026, raising $125,000,000 in gross proceeds, all of which was deposited in a trust account for public shareholders. On February 26, 2026, the underwriter partially exercised its over-allotment option for 15,000 additional units, adding $150,000 in gross proceeds, which were also deposited in the trust account.
IPO of 12,500,000 units at $10.00 per unit closed February 25, 2026, for $125,000,000 gross proceeds
$125,000,000 deposited in the trust account as of February 25, 2026
Over-allotment option partially exercised February 26, 2026 for 15,000 units, adding $150,000 in gross proceeds
Transaction costs totaled $1,225,021, including a $625,000 underwriter's commission
Jacobs Solutions completed an offering of $1.3 billion in senior unsecured notes due 2031 and 2036. The company plans to use the proceeds mainly to fund the cash consideration for its acquisition of the remaining shares of PA Consulting Group, with the rest going to repay revolving and term loan debt if the deal is delayed or not completed. For shareholders, the filing shows the company taking on new long-term debt to finance a large acquisition.
$800 million of 4.750% Senior Notes due March 3, 2031, and $500 million of 5.375% Senior Notes due March 3, 2036
Interest is paid semi-annually on March 3 and September 3, starting September 3, 2026
Proceeds are intended to finance cash consideration for the acquisition of PA Consulting Group's remaining shares; if the deal is not completed, proceeds will repay revolving and term loan borrowings
Notes are fully guaranteed by subsidiary Jacobs Engineering Group Inc. and issued under an indenture with U.S. Bank Trust Company as trustee
Rogers Corporation disclosed that Michael Webb, its Senior Vice President and Chief Administrative Officer, will leave the company on March 13, 2026. He will receive severance under the company's Executive Severance Plan, conditioned on a general release of claims and compliance with non-competition and non-solicitation covenants.
Michael Webb, Senior Vice President and Chief Administrative Officer, departs March 13, 2026
Severance payments and benefits under the Executive Severance Plan, subject to a general release and restrictive covenants
Filing does not name a successor or state any financial figures
Vertiv sold $2.1 billion of senior unsecured notes in four tranches maturing 2036 to 2066 and closed a new $2.5 billion revolving credit facility on March 3, 2026. Proceeds, with cash on hand, repaid its term loan, and the new facility replaced its $800 million asset-based revolver. The filing describes the financing as extending the weighted average maturity of the company's debt, with no change to reported earnings or guidance.
Four note tranches totaling $2.1 billion: $600 million due 2036 at 4.850%, $500 million due 2046 at 5.650%, $500 million due 2056 at 5.800%, and $500 million due 2066 at 5.950%
Company raised $2.08 billion in net proceeds, used with cash on hand to repay the term loan in full
New $2.5 billion revolving credit facility matures in five years, replacing the $800 million asset-based revolver
Debt ratings are Baa3 / BBB- / BBB- from Moody's, S&P and Fitch, with S&P and Moody's each upgrading one notch in February 2026
NextEra Energy sold $2.3 billion of equity units on March 3, 2026, including units sold after the underwriters exercised their overallotment option in full. Each unit bundles a contract requiring holders to buy NEE common stock in about three years, and pays total annual distributions at a 7.375% rate, which means new shares may be issued in the future and the company will receive cash at settlement.
Equity units sold March 3, 2026, totaling $2.3 billion, including the full overallotment option
Stock purchase contracts must be completed by February 15, 2029, at a price per share range of $91.99 to $115.00
Total annual distributions of 7.375%, paid as interest on Debentures and under the stock purchase contracts
Debentures due February 15, 2031 (Series P) and February 15, 2034 (Series Q), guaranteed by NEE
Ultra Clean Holdings issued $600 million of 0.00% convertible senior notes maturing March 15, 2031, including $75 million from the full exercise of the initial purchasers' option. The notes carry no regular interest and are convertible into common stock at an initial price of about $84.75 per share, so conversions could add to the share count, though the company entered capped call transactions costing about $25.1 million to reduce that dilution.
Issued $600 million principal of 0.00% convertible senior notes on March 3, 2026, including $75 million from the full option exercise
Notes mature March 15, 2031 and do not bear regular interest
Initial conversion price of about $84.75 per share; company may settle conversions in cash, shares, or a combination
Capped call transactions cost about $25.1 million, with a cap price of $104.0725 per share
Covista Inc. entered into a credit agreement amendment on March 2, 2026, raising $510 million in new term loans maturing March 2, 2033, and used the proceeds to repay existing term loans and fully redeem its 5.50% Senior Secured Notes due 2028. The amendment cuts the term loan interest rate margin by 0.50%, which lowers borrowing costs, while the redemption payment included about $404,950,000 of note principal.
New term loans total $510 million, maturing March 2, 2033, at Term SOFR plus 2.25% (0.75% SOFR floor) or alternate base rate plus 1.25%
Term loan interest rate margins reduced by 0.50% under the amendment
Notes redeemed at 100.00% of principal, about $404,950,000 of principal plus accrued interest, with the indenture satisfied and discharged
Redemption notice was sent February 13, 2026; Morgan Stanley Senior Funding, Inc. is administrative agent
RLI Corp. completed a public offering of $300 million in 5.375% senior notes due 2036 on March 3, 2026. The company also amended its credit agreement with PNC Bank, raising the aggregate commitment to $150 million and extending maturity to February 26, 2031, which adds $300 million of long-term debt for shareholders to consider.
$300 million aggregate principal of 5.375% Senior Notes due 2036 completed March 3, 2026
Interest payable June 1 and December 1, beginning June 1, 2026; redeemable before March 1, 2036 at the greater of par or a make-whole price
Amended and restated credit agreement with PNC Bank dated February 26, 2026: commitment raised to $150 million, accordion increased to $50 million, maturity extended to February 26, 2031
Indenture does not restrict additional debt or dividends and requires no financial ratios or minimum net worth or liquidity levels
Genevant and Arbutus, both tied to Roivant, agreed to settle their patent infringement litigation against Moderna over LNP technology in its COVID-19 vaccines. Moderna will pay $950 million by July 8, 2026, plus a contingent $1.3 billion tied to a Federal Circuit appeal on 28 U.S.C. §1498. Roivant's board also raised its share repurchase authorization to $1.0 billion, including the previously approved $500 million.
Moderna to pay a noncontingent $950 million lump sum on or before July 8, 2026
Additional $1.3 billion contingent payment depends on the Federal Circuit's §1498 ruling; a partial outcome yields a prorated amount
Board increased the share repurchase program to up to $1.0 billion, funded with cash on hand, with no expiration date
Box reported fourth-quarter fiscal 2026 revenue of $305.9 million, up 9%, and GAAP diluted EPS of $0.47, down from $1.12 a year earlier, a period that included a $1.04 tax benefit. Non-GAAP diluted EPS rose to $0.49 from $0.42. For fiscal 2027, Box expects revenue of about $1.275 billion and GAAP EPS of about $0.45, compared with $0.58 in fiscal 2026, so shareholders face a mixed picture of higher revenue and non-GAAP profit alongside lower GAAP earnings.
Q4 revenue of $305.9 million, up 9%; GAAP operating income of $31.2 million versus $17.9 million a year earlier.
Q4 non-GAAP diluted EPS of $0.49 versus $0.42; GAAP diluted EPS of $0.47 versus $1.12, with the prior year including a $1.04 tax benefit.
FY27 guidance: revenue of about $1.275 billion (up 8%), non-GAAP EPS of about $1.55, and GAAP EPS of about $0.45.
In Q4 Box repurchased 4.4 million shares for about $126 million; about $59 million of buyback capacity remained as of January 31, 2026.
On March 3, 2026, Reinsurance Group of America completed a $400 million offering of 6.375% fixed-rate reset subordinated debentures due 2056, with net proceeds of about $396 million before expenses. The debt is unsecured and ranks junior to the company's senior indebtedness, and the company says it plans to use the proceeds for general corporate purposes, which may include refinancing debt.
$400 million principal amount issued at 100% of principal; net proceeds of about $396 million after underwriting discounts and before expenses.
Fixed 6.375% interest until September 15, 2036, then resets to the Five-Year Treasury Rate plus 2.344%; matures September 15, 2056.
Interest paid semi-annually on March 15 and September 15, beginning September 15, 2026; redeemable under certain conditions, including a par call period before each reset date.
Offering was made under a shelf registration; underwriters were BofA Securities, J.P. Morgan Securities, U.S. Bancorp Investments and Wells Fargo Securities.
CrowdStrike reported fourth-quarter fiscal 2026 results for the quarter ended January 31, 2026. Revenue rose 23% to $1.31 billion, and GAAP net income attributable to CrowdStrike was $38.7 million, compared with a loss of $86.3 million a year earlier. The company also gave fiscal 2027 total revenue guidance of $5.87 billion to $5.93 billion, which matters to shareholders as a forward view of growth.
Q4 total revenue was $1.31 billion, up 23% from $1.06 billion; ending ARR reached $5.25 billion, up 24%
GAAP net income attributable to CrowdStrike was $38.7 million, or $0.15 per diluted share, versus a loss of $86.3 million, or $0.35 per share, a year earlier
Fiscal 2027 total revenue guidance is $5.87 billion to $5.93 billion; Q1 fiscal 2027 total revenue guidance is $1.36 billion to $1.36 billion
Subsequent to January 31, 2026, through March 2, 2026, the company repurchased shares for $50.6 million, with $949.4 million remaining under the program
Intel said board chair Frank Yeary will retire from the board at the conclusion of the 2026 Annual Meeting and will not stand for reelection. Dr. Craig H. Barratt, an independent director since November 2025, will succeed him as independent chair, and the board size will shrink from twelve to eleven directors. The filing involves board leadership and governance only and contains no financial results.
Frank Yeary, chair since 2023 and director since 2009, will retire after the Annual Meeting on May 13, 2026
Dr. Craig H. Barratt will become independent chair effective following the May 13, 2026 Annual Stockholders' Meeting
Board size will be reduced from twelve to eleven directors upon conclusion of the 2026 Annual Meeting
Century Aluminum said its previously issued financial statements for fiscal 2023 and 2024 and several 2024-2025 interim periods should no longer be relied upon. The restatement stems from a change to fully consolidate its Jamalco production assets, after SEC staff disagreed with the company's view that the change was immaterial. The company said the change does not affect net income attributable to Century stockholders, but it expects to report a material weakness in internal controls.
Affected periods include fiscal years ended December 31, 2023 and 2024, and interim periods through September 30, 2025.
2024 gross profit as restated is $172.0 million, down from $185.0 million as previously reported; 2023 gross profit is $87.6 million, down from $91.9 million.
Total assets at December 31, 2024 rise to $2,120.0 million from $1,939.4 million; net income attributable to Century stockholders is unchanged.
The Audit Committee made the conclusion on March 2, 2026, and the company expects a material weakness in internal controls.
STAAR Surgical reported fourth-quarter 2025 net sales of $57.8 million, up 18.1%, and a narrower net loss of $18.3 million versus $34.2 million a year earlier. For the full year, net sales fell 23.7% to $239.4 million and the net loss widened to $80.4 million, or $1.62 per share, from $20.2 million, or $0.41 per share. Shareholders face a mixed picture: quarterly results improved, but the annual decline and larger loss reflect the China inventory reduction and merger-related costs.
Q4 2025 net sales $57.8 million, up 18.1%; net sales excluding China $40.3 million, down 2.1%
Q4 2025 net loss $(18.3) million, or $(0.37) per share, versus $(34.2) million, or $(0.69) per share, a year earlier
Full-year 2025 net loss $(80.4) million, or $(1.62) per share; Q4 included $11.2 million in costs tied to the terminated Alcon merger
Cash, cash equivalents and investments available for sale were $187.5 million at January 2, 2026, with no outstanding debt
On February 26, 2026, subsidiary Hainan Helpson Medical & Biotechnology agreed to acquire the ownership of an invention patent for Prinsepia Utilis Esterol Sublingual Tablets from Xiaoyan Zhang. The $6.93 million transfer price will be paid in company common stock at $0.55 per share, meaning the company is to issue 12,600,000 restricted shares that are not registered under the Securities Act.
Agreement dated February 26, 2026, between subsidiary Helpson and Xiaoyan Zhang, a technology transfer covering an invention patent for sublingual tablets
Transfer price of $6.93 million, paid in common stock at $0.55 per share
Company to issue an aggregate of 12,600,000 restricted shares, offered under the Regulation S exemption to a non-U.S. person in an offshore transaction
Transferor or a designated third party will provide technical services, including product research and development and registration support
Ross Stores reported fourth-quarter fiscal 2025 sales up 12% to $6.6 billion and diluted earnings per share of $2.00, above its guidance of $1.77 to $1.85. The company projected fiscal 2026 EPS of $7.02 to $7.36, compared with $6.61 in fiscal 2025, and approved a new two-year $2.55 billion stock buyback and a 10% increase in its quarterly dividend, which means more cash returned to shareholders.
Q4 sales rose 12% to $6.6 billion, with comparable store sales up 9%.
Q4 diluted EPS of $2.00, compared with $1.79 a year earlier and guidance of $1.77 to $1.85.
Q1 fiscal 2026 EPS guidance of $1.60 to $1.67 vs. $1.47; full-year fiscal 2026 guidance of $7.02 to $7.36 vs. $6.61.
New two-year $2.55 billion buyback for fiscal 2026 and 2027; quarterly dividend raised 10% to $0.445 per share, payable March 31, 2026.
On March 3, 2026, in connection with the First Closing, Duke Energy's subsidiaries and an unnamed investor entered an amended and restated operating agreement for Florida Progress, LLC. The agreement gives the investor limited governance rights tied to its anticipated 19.7% ownership and sets out investor protections, including approval rights over certain major decisions and a right to require Progress Energy to buy the investor's interests under specified circumstances.
Investor's anticipated ownership of Florida Progress is 19.7%
Board of Florida Progress will have 11 managers: two nominated by the investor and nine by Progress Energy
Investor can require Progress Energy to acquire its membership interests in certain circumstances, subject to minimum ownership thresholds
Full agreement filed as Exhibit 10.1, dated March 3, 2026
Moog entered into an Eighth Amended and Restated Loan Agreement on February 26, 2026, with lenders and HSBC Bank USA as administrative agent. The amendment extends the maturity of the credit facility from October 27, 2027 to February 26, 2031, which pushes out the date by which the company must repay the borrowings. The filing does not state the facility size or pricing terms.
Agreement dated February 26, 2026, amends the Seventh Amended and Restated Loan Agreement dated May 30, 2025
Credit facility maturity extended from October 27, 2027 to February 26, 2031
HSBC Bank USA, National Association is administrative agent; full agreement filed as Exhibit 10.1
Trex entered an accelerated share repurchase (ASR) with Wells Fargo under a confirmation dated February 26, 2026, and paid a $100 million prepayment on February 27, 2026. The company received an initial delivery of about 1.9 million shares, and the final number of shares repurchased will depend on Trex's average stock price during the calculation period, so the total is not yet known. The prepayment was funded with borrowings under the company's line of credit.
Prepayment of $100 million to Wells Fargo made on February 27, 2026
Initial delivery of about 1.9 million shares, valued at about 80% of the prepayment based on the February 26, 2026 closing price
Calculation period runs from February 27, 2026 to May 21, 2026, with possible early termination or acceleration; Wells Fargo may accelerate the valuation date beginning April 9, 2026
On March 3, 2026, Pinterest agreed to sell $1 billion of 1.75% convertible senior notes due 2031 to Elliott, with closing expected on or about March 5, 2026. The company said it will use the proceeds for a $1 billion accelerated share repurchase, and its board authorized a new $3.5 billion buyback program that replaces the existing one. The notes convert at an initial price of about $22.72 per share, so conversion could add shares outstanding.
Elliott to buy $1 billion of notes at 1.75% interest, maturing March 1, 2031; closing expected on or about March 5, 2026
Initial conversion price of about $22.72 per share, a 30% premium to the March 2, 2026 closing price
$1 billion accelerated share repurchase with Goldman Sachs; initial delivery of about 80% of expected shares; final settlement no later than May 1, 2026
Board-approved $3.5 billion program leaves about $2.5 billion after the ASR; company intends up to $500 million more under a Rule 10b5-1 plan
The Cigna Group said Brian Evanko, its president and chief operating officer, will become chief executive on July 1, 2026, succeeding David Cordani, who retires as CEO and becomes executive chair. Evanko also joins the board effective April 1, 2026, and the company reaffirmed its 2026 outlook, including adjusted income from operations of at least $30.25 per share. For shareholders, the filing sets a planned leadership transition and leaves the 2026 financial outlook unchanged.
Brian Evanko, 49, becomes CEO on July 1, 2026; he has been president and chief operating officer since March 2025 and was chief financial officer from January 2021 to January 2024
David Cordani retires as CEO on July 1, 2026 and becomes executive chair; Eric Wiseman becomes Chair of the Corporate Governance Committee as Eric Foss becomes lead independent director on April 1, 2026
Evanko's annual base salary will be $1.3 million and his long-term incentive target $15.1 million, effective July 1, 2026
Reaffirmed 2026 outlook: adjusted income from operations of at least $30.25 per share, Evernorth pre-tax adjusted income of at least $6.9 billion, and Cigna Healthcare pre-tax adjusted income of at least $4.5 billion
TXNM Energy entered a Distribution Agreement on March 3, 2026, allowing it to sell up to $125 million of common stock through sales agents, with optional forward stock purchase transactions. The company is not obligated to make any sales, and the filing does not say how much stock has been sold. Sales would add shares outstanding, which could dilute existing shareholders, though the proceeds would support the company's funding needs.
Aggregate sales price capped at $125 million of common stock, no par value, through BofA Securities, MUFG Securities Americas and Scotia Capital (USA) as sales agents
Company pays sales agents a commission of up to 2% of gross sales price, plus certain expenses
Sales will be made under a Form S-3ASR that became automatically effective on February 28, 2025, with a prospectus supplement dated March 3, 2026
Company may elect cash or net share settlement of forward agreements, and forward purchasers can accelerate settlement
Target reported fourth-quarter 2025 net sales of $30.5 billion, down 1.5% from a year earlier, and GAAP diluted EPS of $2.30 versus $2.41, while adjusted EPS rose to $2.44. For full-year 2025, net sales fell 1.7% to $104.8 billion and GAAP EPS fell to $8.13 from $8.86, with adjusted EPS at $7.57. The company guided 2026 GAAP and adjusted EPS to $7.50 to $8.50 and net sales growth of around 2%.
Q4 2025 net sales $30.5 billion, down 1.5%; comparable sales down 2.5%
Q4 GAAP EPS $2.30 included 15 cents of business transformation costs; adjusted EPS $2.44 versus $2.41 a year earlier
Full-year 2025 GAAP EPS $8.13 versus $8.86; adjusted EPS $7.57 excludes $593 million of interchange fee settlement gains
2026 guidance: GAAP and adjusted EPS $7.50 to $8.50; Q1 EPS expected flat to up slightly from $1.30
Versant Media Group reported full-year 2025 results showing declines in revenue, net income and Adjusted EBITDA compared with 2024. The company also declared a $0.375 per share quarterly dividend and authorized its first share repurchase program of up to $1 billion, which matters to shareholders as a new capital return commitment alongside weaker results.
2025 revenue was $6.69 billion, down 5.3% from $7.06 billion in 2024
Net income attributable to Versant was $930 million, down 31.8% from $1.36 billion
Adjusted EBITDA was $2.42 billion, down 14.5%; Standalone Adjusted EBITDA was $2.18 billion, down 9.1%
Quarterly dividend of $0.375 per share is payable April 22, 2026 to holders of record on April 1, 2026
Best Buy reported fourth-quarter fiscal 2026 results for the quarter ended January 31, 2026. Revenue fell to $13.81 billion from $13.95 billion and comparable sales declined 0.8%, but diluted EPS rose to $2.56 from $0.54 a year earlier, and adjusted diluted EPS was $2.61 versus $2.58. The company also guided FY27 adjusted diluted EPS to $6.30 to $6.60 and raised its quarterly dividend 1% to $0.96.
Q4 diluted EPS was $2.56 versus $0.54 a year earlier; adjusted diluted EPS was $2.61 versus $2.58.
Revenue was $13.81 billion versus $13.95 billion; Domestic comparable sales fell 0.8%, with online comparable sales down 2.3%.
FY27 guidance: revenue of $41.2 billion to $42.1 billion and adjusted diluted EPS of $6.30 to $6.60.
Quarterly dividend increases 1% to $0.96 per share, payable April 14, 2026, to holders of record March 24, 2026.
AutoZone reported results for the 12-week second quarter ended February 14, 2026. Net sales rose 8.1% to $4.3 billion and total company same store sales rose 5.2%, but operating profit fell 1.2% to $698.5 million and diluted earnings per share fell to $27.63 from $28.29. The company attributed the gross margin decline mainly to a 138 basis point non-cash LIFO charge.
Net sales were $4.3 billion, up 8.1% from the prior-year quarter; total company same store sales rose 5.2%, or 3.3% in constant currency.
Gross profit margin was 52.5%, down 137 basis points, driven by a 138 basis point non-cash LIFO charge.
Net income was $468.9 million versus $487.9 million a year earlier; diluted EPS was $27.63 versus $28.29.
The company repurchased shares for $310.8 million in the quarter and had $1.4 billion remaining under its repurchase authorization.
Kontoor Brands reported fourth-quarter and full-year 2025 results on March 3, 2026, and gave initial 2026 guidance. Fourth-quarter revenue and reported diluted EPS rose from a year earlier, though much of the revenue gain came from the Helly Hansen acquisition, and full-year reported EPS fell to $4.05 from $4.36. The company expects 2026 revenue of $3.40 to $3.45 billion and adjusted EPS of $6.40 to $6.50, and plans $225 million of voluntary term loan payments.
Q4 2025 revenue was $1.02 billion, up 46%; up 2% excluding Helly Hansen and the 53rd week.
Q4 reported diluted EPS was $1.31 versus $1.14 a year earlier; adjusted EPS was $1.73, up 26%.
2026 outlook: revenue of $3.40 to $3.45 billion, adjusted EPS of $6.40 to $6.50, and cash from operations of about $425 million.
Full-year 2025 reported diluted EPS was $4.05 versus $4.36 in 2024; net income fell 7%.
Wyndham Hotels & Resorts appointed Amit Sripathi, previously its Chief Development Officer – North America, as Chief Financial Officer effective March 3, 2026, replacing interim CFO Kurt Albert, who departs March 4, 2026 and moves to a nine-month advisory role. The company also reaffirmed its full-year 2026 outlook, which it first gave in its fourth-quarter 2025 earnings materials released February 18, 2026, so the change in finance leadership does not come with a guidance change.
Amit Sripathi appointed CFO effective March 3, 2026, with a base salary of $650,000 and a target annual incentive of 100% of base salary
Kurt Albert, interim CFO since November, departs March 4, 2026 and receives $450,000 in advisory fees over a nine-month transition period
Company reaffirmed its full-year 2026 outlook from its February 18, 2026 fourth-quarter 2025 earnings materials
David Wilner named Chief Development Officer – North America
THOR Industries reported fiscal second quarter 2026 results for the three months ended January 31, 2026, with net sales of $2.13 billion, up 5.3% from a year earlier, and net income attributable to THOR of $17.8 million, or $0.34 per diluted share, compared with a loss of $551,000 a year earlier. The company left its full-year fiscal 2026 guidance unchanged, citing recent geopolitical events that it said created too much short-term uncertainty to raise the outlook. Management said net income was aided by gains tied to real estate transactions and asset sales.
Net sales of $2.13 billion, up 5.3%; gross profit margin of 11.8% versus 12.1% a year earlier
Net income attributable to THOR of $17.8 million versus a loss of $551,000; diluted EPS of $0.34 versus $(0.01)
Full-year fiscal 2026 guidance held: net sales of $9.0 billion to $9.5 billion and diluted EPS of $3.75 to $4.25
North American Motorized net sales rose 29.3%, while the European RV segment posted a pre-tax loss of $12.3 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.